Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study)

JV Luciano; F D'Amico; A Feliu-Soler; LM McCracken; J Aguado; MT Peñarrubia-María; M Knapp; A Serrano-Blanco; J García-Campayo

doi:10.1016/j.jpain.2017.03.001

Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study)

JV Luciano, F D'Amico, A Feliu-Soler, LM McCracken, J Aguado, MT Peñarrubia-María, M Knapp, A Serrano-Blanco, J García-Campayo

Department of Clinical and Health Psychology

Research output: Contribution to journal › Article › Research › peer-review

33 Citations (Scopus)

Original language	English
Journal	Journal of Pain
DOIs	https://doi.org/10.1016/j.jpain.2017.03.001
Publication status	Published - Mar 2017

Access to Document

10.1016/j.jpain.2017.03.001

Cite this

Luciano, JV., D'Amico, F., Feliu-Soler, A., McCracken, LM., Aguado, J., Peñarrubia-María, MT., Knapp, M., Serrano-Blanco, A., & García-Campayo, J. (2017). Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study). Journal of Pain. https://doi.org/10.1016/j.jpain.2017.03.001

@article{0166ea39226f46149584a3e4fb5f3154,

title = "Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study)",

author = "JV Luciano and F D'Amico and A Feliu-Soler and LM McCracken and J Aguado and MT Pe{\~n}arrubia-Mar{\'i}a and M Knapp and A Serrano-Blanco and J Garc{\'i}a-Campayo",

year = "2017",

month = mar,

doi = "10.1016/j.jpain.2017.03.001",

language = "English",

journal = "Journal of Pain",

issn = "1526-5900",

publisher = "Churchill Livingstone",

}

Luciano, JV, D'Amico, F, Feliu-Soler, A, McCracken, LM, Aguado, J, Peñarrubia-María, MT, Knapp, M, Serrano-Blanco, A & García-Campayo, J 2017, 'Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study)', Journal of Pain. https://doi.org/10.1016/j.jpain.2017.03.001

TY - JOUR

T1 - Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study)

AU - Luciano, JV

AU - D'Amico, F

AU - Feliu-Soler, A

AU - McCracken, LM

AU - Aguado, J

AU - Peñarrubia-María, MT

AU - Knapp, M

AU - Serrano-Blanco, A

AU - García-Campayo, J

PY - 2017/3

Y1 - 2017/3

UR - http://europepmc.org/abstract/med/28342891

U2 - 10.1016/j.jpain.2017.03.001

DO - 10.1016/j.jpain.2017.03.001

M3 - Article

C2 - 28342891

SN - 1526-5900

JO - Journal of Pain

JF - Journal of Pain

ER -

Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study)

Access to Document

Other files and links

Cite this